Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.68 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | ITGA4 | P13612 | 5/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.51 |
| ▸ | MME | P08473 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ITGB1 | P05556 | 4/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.49 |
| ▸ | ACE | P12821 | 2/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.49 |
| ▸ | ITGA2 | P17301 | 1/20 | 0.48 |
| ▸ | ITGB7 | P26010 | 1/20 | 0.48 |
| ▸ | FPR2 | P25090 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28965814 | 0.91 | L3MBTL1 (0.67) | L3MBTL1NAALAD2ALDH1A1ITGA4PTPN1 | |
| SCHEMBL28965815 | 0.91 | L3MBTL1 (0.67) | L3MBTL1NAALAD2ALDH1A1ITGA4PTPN1 | |
| SCHEMBL4180754 | 0.88 | ATM (0.59) | L3MBTL1ALDH1A1KMT2A | |
| SCHEMBL4170016 | 0.79 | L3MBTL1 (0.79) | L3MBTL1NAALAD2ITGA4PTPN1KMT2A | |
| SCHEMBL15145361 | 0.78 | L3MBTL1 (0.68) | L3MBTL1NAALAD2ITGA4PTPN1MME | |
| SCHEMBL1696507 | 0.77 | MME (0.67) | L3MBTL1NAALAD2PTPN1MMEACE | |
| SCHEMBL547223 | 0.77 | MME (0.67) | L3MBTL1NAALAD2PTPN1MMEACE | |
| SCHEMBL547222 | 0.77 | MME (0.67) | L3MBTL1NAALAD2PTPN1MMEACE | |
| SCHEMBL18180178 | 0.77 | NAALAD2 (0.78) | L3MBTL1NAALAD2ALDH1A1MMEKMT2A | |
| SCHEMBL19969196 | 0.77 | NAALAD2 (0.78) | L3MBTL1NAALAD2ALDH1A1MMEKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090047379-A1 | Benzamide Compounds Useful as High Potency Sweet Taste Enhancers | DEWIS MARK L | 2009-02-19 | — | — | US | disclosed |
| US-20090047379-A1 | Benzamide Compounds Useful as High Potency Sweet Taste Enhancers | DEWIS MARK L | 2009-02-19 | — | — | US | disclosed |
| US-20090047379-A1 | Benzamide Compounds Useful as High Potency Sweet Taste Enhancers | DEWIS MARK L | 2009-02-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090047379-A1 | Benzamide Compounds Useful as High Potency Sweet Taste Enhancers | TAS2R10, TAS2R50, TAS2R8 | L3MBTL1 4231/4885NAALAD2 396/4885ALDH1A1 818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.